ATRC

AtriCure, Inc. News Headlines

$16.31
*  
0.21
 negative 
1.3%
Get ATRC Alerts
*Delayed - data as of Apr. 17, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Zacks Rank #5 Additions for Thursday - Tale of the Tape
4/10/2014 9:30:01 AM - Zacks.com

Zacks Rank #5 Additions for Tuesday - Tale of the Tape
4/8/2014 9:30:01 AM - Zacks.com

Zacks Rank #5 Additions for Friday - Tale of the Tape
4/4/2014 9:30:01 AM - Zacks.com

Zacks Rank #5 Additions for Wednesday - Tale of the Tape
3/19/2014 9:30:01 AM - Zacks.com

Zacks Rank #5 Additions for Thursday - Tale of the Tape
3/13/2014 9:30:01 AM - Zacks.com

AtriCure Q4 13 Earnings Conference Call At 4:30 PM ET
2/27/2014 3:00:00 PM - RTT News

Follow The M&A Money To Small- And Mid-Cap Cardiovascular Medtechs: Jason Mills
1/3/2014 1:50:00 PM - Seeking Alpha

Healthcare Stocks Adding to Earlier Losses; AtriCure Jumps Nearly 12% After Q3 EPS, Revenue Beats
10/30/2013 2:42:57 PM - MT Newswires

Sector Update: Healthcare
10/30/2013 2:41:05 PM - MT Newswires

AtriCure Inc. (ATRC) Enters Overbought Territory - Tale of the Tape
9/18/2013 5:57:59 AM - Zacks.com

Good News for Hospira, Shares up - Analyst Blog
7/2/2013 11:30:01 AM - Zacks.com

Positive Data for COV's Pipeline - Analyst Blog
6/21/2013 12:30:44 PM - Zacks.com

AtriCure Mid-Trial Results Highly Encouraging
6/18/2013 12:59:00 PM - Seeking Alpha

Positive Data for COV's Solitaire - Analyst Blog
6/17/2013 1:25:01 PM - Zacks.com

Abbott Progresses with Absorb in Japan - Analyst Blog
6/14/2013 6:30:01 PM - Zacks.com

FDA Nod for STJ's Ellipse & Assura - Analyst Blog
6/13/2013 6:30:01 PM - Zacks.com

Symmetry Provides Dismal 2013 View - Analyst Blog
6/11/2013 3:28:01 PM - Zacks.com

Abbott Labs' HPV Test in Canada - Analyst Blog
5/31/2013 5:27:42 PM - Zacks.com

Back to Neutral on Hospira - Analyst Blog
5/28/2013 2:28:02 PM - Zacks.com

Covidien's ENB Adopted by ACCP - Analyst Blog
5/23/2013 11:30:09 AM - Zacks.com

CE Mark for Abbott's Xience Xpedition 48 - Analyst Blog
5/22/2013 7:26:24 PM - Zacks.com

FDA Nod for COV's Advanced Nellcor - Analyst Blog
5/21/2013 10:29:13 AM - Zacks.com

CE Mark for STJ's ILUMIEN OPTIS - Analyst Blog
5/17/2013 2:29:42 PM - Zacks.com

Stryker Reiterated at Neutral - Analyst Blog
5/17/2013 1:30:29 PM - Zacks.com

Covidien Prices Senior Notes - Analyst Blog
5/16/2013 9:29:17 AM - Zacks.com